HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 94 filers reported holding HARPOON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $804 | -62.1% | 1,133 | -60.3% | 0.00% | – |
| Q1 2023 | $2,122 | +9.5% | 2,851 | +6.7% | 0.00% | – |
| Q4 2022 | $1,938 | -3.1% | 2,671 | +14.8% | 0.00% | – |
| Q3 2022 | $2,000 | -99.2% | 2,327 | -98.2% | 0.00% | -100.0% |
| Q2 2022 | $254,000 | -44.2% | 132,791 | +45.0% | 0.00% | 0.0% |
| Q1 2022 | $455,000 | -52.8% | 91,579 | -28.3% | 0.00% | -50.0% |
| Q4 2021 | $965,000 | -4.5% | 127,800 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $1,011,000 | -43.2% | 128,022 | -0.2% | 0.00% | -33.3% |
| Q2 2021 | $1,779,000 | +44375.0% | 128,249 | +75787.0% | 0.00% | – |
| Q1 2021 | $4,000 | – | 169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |